3-Chloro-2-(4-fluorophenyl)pyridine, 98%, 500mg

1,1-Ethanediol Diacetate>98.0%(GC)25g

1-Bromo-5-fluoro-4-isopropoxy-2-methylbenzene, 98%, 1g

1-METHYLOCTAHYDRO-1,6-NAPHTHYRIDIN-2(1H)-ONE HCL, 95.0%, 250mg

(3R,5S)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}pyrrolidin-3-ol, 95%, 10g

2-Bromo-3,5-dimethyl-benzoic acid, 95.0%, 10g

Acetylacetonatobis(ethylene) rhodium(I), 95%, 100mg

2-Amino-5-(methylthio)pyridine, 95.0%, 100mg

(2R,4S)-1-(TERT-BUTOXYCARBONYL)-4-METHOXYPYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 500mg

6-hydroxy-5-[(1E)-2-phenyldiazen-1-yl]-2-(propylsulfanyl)-3,4-dihydropyrimidin-4-one, 98%, 100mg

4-Chloro-2-(1-piperidino)-5-thiazolecarboxaldehyde, 95.0%, 250mg

tert-Butyl (3aS,7aS)-octahydro-6H-pyrrolo[2,3-c]pyridine-6-carboxylate, 98%, 100mg

E-Plan phase EPLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.95 mm